Elsevier

Regulatory Peptides

Volume 92, Issues 1–3, 25 August 2000, Pages 37-43
Regulatory Peptides

Dynamic regulation of leptin entry into brain by the blood–brain barrier

https://doi.org/10.1016/S0167-0115(00)00147-6Get rights and content

Abstract

Regulation of the transport of leptin across the blood–brain barrier (BBB) may be crucial for its effects on food ingestion and obesity and may be responsible for ‘leptin resistance’. This review summarizes current studies of leptin indicating a dynamic role of the BBB. It includes evidence for its susceptibility to change by physiological stimuli such as starvation, refeeding, and time of day. Although the short form of the leptin receptor is involved in leptin transport, it appears that other mechanisms of entry also exist. Regardless, the BBB is intimately involved with the regulation of the actions of leptin.

Section snippets

Overview

Leptin has not yet fulfilled its promise as the magic bullet of obesity, partly because of ‘leptin resistance’. Leptin resistance, in which high levels of leptin in the blood of obese people and rodents do not reach the brain, could be explained by a defect of leptin crossing the blood–brain barrier (BBB).

The BBB is mainly composed of specialized endothelial cells of cerebral capillaries which are devoid of fenestrations or transendothelial channels and are joined by tight junctions. The

Leptin resistance

It is the concentration of leptin in the CNS, not in the periphery, that correlates with the reduction of body weight. Since leptin is mainly synthesized by adipose tissue in the periphery, limitation of the blood-to-brain transport of leptin has been hypothesized to explain the obesity referred to as leptin resistance. In obesity, increased concentrations of leptin in blood fail to reduce food ingestion [13], [14], [15], [16], [17]. This is reflected in the decreased ratio of blood to CSF

Multiple-time regression analysis

Multiple-time regression analysis [25] has been the most frequently used method for study of the influx into brain of bioactive peptides and proteins having relatively low penetration across the BBB. This technique is based on a mathematical model originally generated by Patlak, Blasberg and Fenstermacher [26], [27]. In this method, radiolabeled leptin is given to the anesthetized animal in an intravenous bolus injection, and the radioactivity of leptin in blood and CNS is measured

Mice

The entry rate (Ki) of [125I]leptin after i.v. injection in mice is 5.87×10−4 ml/g min, significantly greater than that for [99mTc]albumin [10]. Inclusion of 1 μg/mouse of unlabeled leptin in the injection decreases the Ki by 93% to 0.36×10−4 ml/g min, showing the self-inhibition characteristic of a saturable transport system. Inhibition of the transport of [125I]leptin by unlabeled leptin is dose-dependent. Saturation appears to be highly selective; we have tested a large number of ingestive

Further studies of saturation: roles of age, weight, and adiposity

With saturation of a transport system, an excess amount of the substance to be transported does not enhance the rate of influx. This excess could occur when the endogenous concentration of leptin in blood is increased. As with insulin, levels of leptin in blood are correlated with body weight, increasing with obesity [44]. A confounding factor, however, is the age of the study subject, as the concentration of leptin may decrease with aging [44].

In a study of mice of different ages and weights,

Body fat: direct or indirect effects?

An increase in body fat could affect the transport of leptin across the BBB in at least two main ways: self-inhibition of the transport system by increased production of leptin and neuroendocrine modulation. Increased adiposity, rather than aging or increased non-fat body mass, is a major factor in decreasing the entry of leptin into the brain [45]. Despite this direct effect, adipose tissue also might cause endocrine changes that indirectly affect the transport system. In a preliminary study,

Conclusions

Although all the factors controlling the blood-to-brain transport of leptin across the BBB have not been determined, it is clear that there is a transport system for leptin that is saturable and therefore susceptible to physiological and pharmacological manipulation. The results with leptin also serve to emphasize the dynamic regulatory role the BBB can play, even with molecules as large as the polypeptide leptin.

Acknowledgements

Supported by NIH (DK54880) and the VA.

References (53)

  • W.A. Banks et al.

    Tyr-MIF-1 and met-enkephalin share a saturable blood–brain barrier transport system

    Peptides

    (1987)
  • G.A. Maresh et al.

    Peptide transport system 1 (PTS-1) for Tyr-MIF-1 and Met-enkephalin differs from the receptors for either

    Brain Res

    (1999)
  • W. Pan et al.

    Entry of EGF into brain is rapid and saturable

    Peptides

    (1999)
  • W. Pan et al.

    TGF α and the blood-brain barrier: accumulation in cerebral vasculature

    Exp Neurol

    (1999)
  • W.A. Banks et al.

    Impaired transport of leptin across the blood–brain barrier in obesity

    Peptides

    (1999)
  • A.J. Kastin et al.

    Fasting, but not adrenalectomy, reduces transport of leptin into the brain

    Peptides

    (2000)
  • G.A. Bray et al.

    Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system

  • G.A. Olson et al.

    Endogenous opiates: 1997

    Peptides

    (1998)
  • A.J. Kastin et al.

    Nonsaturable entry of neuropeptide Y into the brain

    Am J Physiol

    (1999)
  • A.J. Kastin et al.

    Orexin A but not orexin B rapidly enters brain from blood by simple diffusion

    J Pharmacol Exp Ther

    (1999)
  • W.A. Banks et al.

    Radioactively iodinated cyclo(His-Pro) crosses the blood–brain barrier and reverses ethanol-induced narcosis

    Am J Physiol

    (1993)
  • A.J. Kastin et al.

    Agouti-related protein (83–132) aggregates and crosses the blood–brain barrier slowly

    Metabolism

    (2000)
  • A.J. Kastin et al.

    Entry of CART into brain is rapid but not inhibited by excess CART or leptin

    Am J Physiol

    (1999)
  • J.M. Martins et al.

    Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone

    Neuroendocrinology

    (1996)
  • A.J. Kastin et al.

    Phe13,Tyr19-Melanin-concentrating hormone and the blood–brain barrier: role of protein binding

    J Neurochem

    (2000)
  • H.A. Koistinen et al.

    Circulating leptin has saturable transport into intrathecal space in humans

    Eur J Clin Invest

    (1998)
  • Cited by (0)

    View full text